Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura

Overview of attention for article published in Drug Design, Development and Therapy, April 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 54 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 8,874 followers.

Our new paper entitled #Caplacizumab as an emerging #treatment option for acquired #thromboticthrombocytopenicpurpura (#TTP) @DovePress https://t.co/adn37uQ4iR

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.